Senseonics, Incorporated is a leading medical technology company based in Germantown, MD. They are the creators of the first and only Long-term Implantable CGM (Continuous Glucose Monitoring) system, known as Eversense, which offers up to 180 days of continuous glucose monitoring for patients with diabetes.
The company is dedicated to providing accurate and safe glucose monitoring solutions, as demonstrated by their ongoing research and publications evaluating the effectiveness and acceptance of their next-generation implantable and transcutaneous CGM systems. Senseonics' innovative technology aims to improve the lives of individuals with diabetes by offering a long-term solution for continuous glucose monitoring.
Generated from the website